Agios Pharmaceuticals Faces Setback as Tebapivat Study Fails, Highlighting Persistent Challenges in Sickle Cell Disease Drug Development
The clinical trial failure of Agios Pharmaceuticals’ investigational drug, tebapivat, marks a significant setback for...
